Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.235
+0.115 (2.79%)
Sep 30, 2026, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 7.64 billion as of September 30, 2026. Its market cap has decreased by -43.15% in one year.
Market Cap
7.64B
Enterprise Value
8.06B
Revenue
1.14B
Ranking
n/a
PE Ratio
26.76
Stock Price
4.24
ChartMarket Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 7.64B, a decrease of -35.47%. That is a compound annual growth rate of -9.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 7.64B | -14.79% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 9.03B |
| Suzhou Ribo Life Science | 8.72B |
| CStone Pharmaceuticals | 8.19B |
| Alphamab Oncology | 7.75B |
| LongBio Pharma (Suzhou) | 7.62B |
| Shanghai Haohai Biological Technology | 7.16B |
| CARsgen Therapeutics Holdings | 6.85B |
| Shaanxi Micot Pharmaceutical Technology | 6.60B |